CO5150195A1 - Androgenos novedosos - Google Patents

Androgenos novedosos

Info

Publication number
CO5150195A1
CO5150195A1 CO00016933A CO00016933A CO5150195A1 CO 5150195 A1 CO5150195 A1 CO 5150195A1 CO 00016933 A CO00016933 A CO 00016933A CO 00016933 A CO00016933 A CO 00016933A CO 5150195 A1 CO5150195 A1 CO 5150195A1
Authority
CO
Colombia
Prior art keywords
androgens
new
ester
steroid
atom
Prior art date
Application number
CO00016933A
Other languages
English (en)
Spanish (es)
Inventor
Janjozef Loozen Hubert
Dirk Leysen
Van Der Louw Jaap
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of CO5150195A1 publication Critical patent/CO5150195A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J15/00Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16Masculine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CO00016933A 1999-03-08 2000-03-08 Androgenos novedosos CO5150195A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99200665 1999-03-08

Publications (1)

Publication Number Publication Date
CO5150195A1 true CO5150195A1 (es) 2002-04-29

Family

ID=8239953

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00016933A CO5150195A1 (es) 1999-03-08 2000-03-08 Androgenos novedosos

Country Status (11)

Country Link
US (1) US6881728B1 (https=)
EP (1) EP1163259B1 (https=)
JP (1) JP4749550B2 (https=)
AR (1) AR022852A1 (https=)
AT (1) ATE228143T1 (https=)
AU (1) AU3162200A (https=)
CA (1) CA2359218A1 (https=)
CO (1) CO5150195A1 (https=)
DE (1) DE60000826T2 (https=)
PE (1) PE20001489A1 (https=)
WO (1) WO2000053619A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2258037T3 (es) * 1999-12-02 2006-08-16 Akzo Nobel N.V. Androgenos sustituidos con 14,15-beta-metilen.
ES2305131T3 (es) * 2000-12-11 2008-11-01 N.V. Organon Metileno esteroides como nuevos androgenos.
DE10104327A1 (de) * 2001-01-24 2002-07-25 Schering Ag 11beta-Halogensteroide, deren Herstellung und Verwendung zur Herstellung von Arzneimitteln sowie 11beta-Halogensteroide enthaltende pharmazeutische Präparate
TWI221154B (en) * 2001-09-12 2004-09-21 Akzo Nobel Nv 17alpha-hydroxy-14beta-steroids with hormonal effect
PE20050677A1 (es) 2003-12-22 2005-10-04 Akzo Nobel Nv Esteroides con perfil androgenico y progestagenico mixto

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002746A (en) * 1959-09-25 1977-01-11 Herchel Smith Synthesis of gon-4-enes
US3086027A (en) * 1960-01-22 1963-04-16 Lilly Co Eli 19-nor-4, 9(10)-steroids and process
IE60780B1 (en) * 1987-01-23 1994-08-10 Akzo Nv New 11-aryl steroid derivatives
US5264427A (en) * 1992-01-29 1993-11-23 Research Corporation Technologies, Inc. 20-substituted pregnene derivatives and their use as androgen synthesis inhibitors
US6180682B1 (en) * 1999-01-26 2001-01-30 Virgil A. Place Buccal drug delivery system for use in male contraception

Also Published As

Publication number Publication date
DE60000826D1 (de) 2003-01-02
US6881728B1 (en) 2005-04-19
WO2000053619A1 (en) 2000-09-14
JP2002539135A (ja) 2002-11-19
AU3162200A (en) 2000-09-28
JP4749550B2 (ja) 2011-08-17
PE20001489A1 (es) 2000-12-29
EP1163259B1 (en) 2002-11-20
EP1163259A1 (en) 2001-12-19
CA2359218A1 (en) 2000-09-14
ATE228143T1 (de) 2002-12-15
DE60000826T2 (de) 2003-04-10
AR022852A1 (es) 2002-09-04

Similar Documents

Publication Publication Date Title
CO5271716A1 (es) Cristales de 4- carboxamino 1,2,3,4-tetrahidroquinolina 2- sustituida
MXPA02004770A (es) Composiciones terapeuticas y metodos para su uso.
NO20022506D0 (no) Elektrogenerator for bruk i borehull
CO5290342A1 (es) Conformidad proactiva para pozos de petroleo o de gas
PA8623601A1 (es) Protector para punta de aguja
CO5200785A1 (es) Uso terapeutico de quinazolina
DE69733353D1 (de) Immunsuppressive wirkstoffe und verfahren
CO5210886A1 (es) Aplicacion de compuestos de imidazolidin-2, 4-diona susti- tuida como antalgicos
ES2213707T3 (es) Estimulacion del crecimiento oseo con un derivado peptidico de la trombina.
NO20011274L (no) Flashlagergruppe med indre oppfriskning
CO5271724A1 (es) Uso de agonistas de prostaglandinas para tratar la disfuncion erectil o la impotencia
CO5150195A1 (es) Androgenos novedosos
CO5271732A1 (es) Mecanismo estable de propulsar / repeler
PT1294732E (pt) Compostos de rutenio (ii) para utilizacao na terapia do cancro
CO5280205A1 (es) Forma cristalina de eplerenona .
AR031010A1 (es) Una composicion farmaceutica, util para inhibir el dano celular
ES2186153T3 (es) Sulfato de 5-alfa-pregnan-3-beta-ol-20-ona para el tratamiento de tumores y de los trastornos del snc.
CO5221125A1 (es) Inhibidor de intercambiador de sodio hidrogeno de tipo 1
CO5190678A1 (es) Terapia combinada para el tratamiento de la migrana
CO5271714A1 (es) Cristales de inhibidor del intercambiador de sodio-hidrogeno
CO5440228A1 (es) Tratamiento de la incontinencia urinaria
CO5070652A1 (es) Compuestos esteroides que tienen actividad supresora del apetito
Bach et al. I Know that My Redeemer Lives
Velde et al. RETRACTED CHAPTER: Introduction
ES1038597Y (es) Maquina perfeccionada aplicable para el tratamiento de encimeras de piedra natural y artificial.